Acer Therapeutics Financials
| ACERDelisted Stock | USD 0.81 0.10 14.08% |
With this module, you can analyze Acer financials for your investing period. You should be able to track the changes in Acer Therapeutics individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Acer |
Understanding current and past Acer Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Acer Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Acer Therapeutics' assets may result in an increase in income on the income statement.
The data published in Acer Therapeutics' official financial statements usually reflect Acer Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Acer Therapeutics. For example, before you start analyzing numbers published by Acer accountants, it's critical to develop an understanding of what Acer Therapeutics' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Acer Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acer Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Acer Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acer Therapeutics. Please utilize our Beneish M Score to check the likelihood of Acer Therapeutics' management manipulating its earnings.
Acer Therapeutics Stock Summary
Acer Therapeutics competes with NRx Pharmaceuticals, Pasithea Therapeutics, SAB Biotherapeutics, Lexaria Bioscience, and ZyVersa Therapeutics. Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. Acer Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US00444P1084 |
| Business Address | One Gateway Center, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.acertx.com |
| Phone | 844 902 6100 |
| Currency | USD - US Dollar |
You should never invest in Acer Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Acer Stock, because this is throwing your money away. Analyzing the key information contained in Acer Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Acer Therapeutics Key Financial Ratios
Generally speaking, Acer Therapeutics' financial ratios allow both analysts and investors to convert raw data from Acer Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Acer Therapeutics over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Acer Therapeutics reports annually and quarterly.Acer Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Acer Therapeutics's current stock value. Our valuation model uses many indicators to compare Acer Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acer Therapeutics competition to find correlations between indicators driving Acer Therapeutics's intrinsic value. More Info.Acer Therapeutics is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acer Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acer Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Acer Therapeutics' earnings, one of the primary drivers of an investment's value.Acer Therapeutics Market Pulse
| Quote | 0.81 |
| Change(%) | 14.08 |
| Change | 0.10 |
| Open | 0.71 |
| Low | 0.6 |
| High | 0.81 |
| Volume | 0 |
| Exchange | NASDAQ |
About Acer Therapeutics Financials
What exactly are Acer Therapeutics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Acer Therapeutics' income statement, its balance sheet, and the statement of cash flows. Potential Acer Therapeutics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Acer Therapeutics investors may use each financial statement separately, they are all related. The changes in Acer Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Acer Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Acer Therapeutics Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Acer Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Acer has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Acer Therapeutics' financials are consistent with your investment objective using the following steps:- Review Acer Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Acer Therapeutics' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Acer Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Acer Therapeutics' stock is overvalued or undervalued.
Acer Therapeutics April 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Acer Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Acer Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Acer Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Acer Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Acer Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.52 | |||
| Information Ratio | 0.0509 | |||
| Maximum Drawdown | 123.87 | |||
| Value At Risk | (10.94) | |||
| Potential Upside | 4.94 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Acer Therapeutics information on this page should be used as a complementary analysis to other Acer Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Acer Stock
If you are still planning to invest in Acer Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acer Therapeutics' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |